Not Tagged
Not Tagged
['sarcoma']
personalized residual disease assays show promise to overcome liquid biopsy challenges in sarcomas. new data presented at the asco annual meeting this week showed that tumor-informed assays could detect emerging recurrence ahead of imaging. 